跳至主要内容
临床试验/IRCT20230202057305N1
IRCT20230202057305N1尚未招募2 期

Comparison of efficacy and safety of quadruple regimens containing furazolidone in patients with Helicobacter pylori infection

Shahid Beheshti University of Medical Sciences0 个研究点目标入组 135 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
入组人数
135

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
17 years 至 no limit(—)
性别
All

入选标准

  • Confirmation of H. pylori infection in patients by standard diagnostic methods
  • Over seventeen years of age

排除标准

  • History of known drug sensitivity to the studied drug regimen
  • Having chronic diseases (pulmonary, kidney, liver)
  • Unwillingness to participate in the study
  • Patients treated with other treatment methods such as probiotics, other antibiotics, etc.

研究者

相似试验